These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8943676)

  • 1. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
    Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
    Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.
    Hoefnagel CA
    Eur J Nucl Med; 1994 Jun; 21(6):561-81. PubMed ID: 7915987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
    Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintiscans and carcinoid tumors.
    Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C
    Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIBG and radiolabeled octreotide in neuroendocrine tumors.
    Hoefnagel CA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):137-9. PubMed ID: 9002773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
    Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
    Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
    Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
    J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphic imaging of carcinoid tumours with 131I-metaiodobenzylguanidine.
    Fischer M; Kamanabroo D; Sonderkamp H; Proske T
    Lancet; 1984 Jul; 2(8395):165. PubMed ID: 6146062
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatostatin analogue scintigraphy in carcinoid tumours.
    Kwekkeboom DJ; Krenning EP; Bakker WH; Oei HY; Kooij PP; Lamberts SW
    Eur J Nucl Med; 1993 Apr; 20(4):283-92. PubMed ID: 8491220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
    Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
    Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors.
    Manil L; Edeline V; Lumbroso J; Lequen H; Zucker JM
    J Nucl Med; 1996 Jun; 37(6):893-6. PubMed ID: 8683306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I MIBG/111In octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin.
    Orsolon P; Bagni B
    Minerva Endocrinol; 1995 Jun; 20(2):145-7. PubMed ID: 8531897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
    Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
    Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors.
    Bongers V; de Klerk JM; Zonnenberg BA; de Kort G; Lips CJ; van Rijk PP
    J Nucl Med; 1997 Jul; 38(7):1024-6. PubMed ID: 9225784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.
    Wiseman GA; Kvols LK
    Semin Nucl Med; 1995 Jul; 25(3):272-8. PubMed ID: 7570046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.